Expanded polyglutamine stretches form an 'aggresome'

Neurosci Lett. 2002 May 3;323(3):215-8. doi: 10.1016/s0304-3940(02)00162-3.

Abstract

To understand the pathogenetic mechanisms underlying polyglutamine (polyQ) diseases, we investigated the mechanisms of the formation of aggregate bodies containing expanded polyQ stretches, focusing on dentatorubral-pallidoluysian atrophy (DRPLA). We demonstrated that the expression of a truncated DRPLA protein containing expanded polyQ stretches in COS-7 cells resulted in the formation of perinuclear aggregate bodies that are co-localized with gamma-tubulin, a protein marker for the microtubules-organizing center (MTOC). A collapsed vimentin network surrounded these aggregate bodies. Furthermore, disruption of the microtubules (MTs) with nocodazole resulted in the formation of small aggregate bodies that were scattered throughout the cytoplasm. These findings suggest that the truncated DRPLA proteins containing expanded polyQ stretches unfold and form small aggregate bodies in the cell periphery. These aggregates move on MTs to the MTOC, where they remain as distinct 'aggresomes''.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Brain / metabolism*
  • Brain / pathology
  • Brain / physiopathology
  • COS Cells
  • Cytoplasm / metabolism
  • Cytoplasm / pathology
  • Cytoskeleton / metabolism
  • Cytoskeleton / pathology
  • Green Fluorescent Proteins
  • Inclusion Bodies / metabolism*
  • Inclusion Bodies / pathology
  • Indicators and Reagents
  • Luminescent Proteins / metabolism
  • Macromolecular Substances
  • Microtubule-Organizing Center / metabolism
  • Microtubule-Organizing Center / pathology
  • Microtubules / drug effects
  • Microtubules / metabolism
  • Microtubules / pathology
  • Myoclonic Epilepsies, Progressive / metabolism*
  • Myoclonic Epilepsies, Progressive / pathology
  • Myoclonic Epilepsies, Progressive / physiopathology
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology
  • Neurodegenerative Diseases / physiopathology
  • Neurons / metabolism*
  • Neurons / pathology
  • Nocodazole / pharmacology
  • Peptides / genetics
  • Peptides / metabolism*
  • Trinucleotide Repeat Expansion / genetics*
  • Tubulin / metabolism
  • Vimentin / metabolism

Substances

  • Antineoplastic Agents
  • Indicators and Reagents
  • Luminescent Proteins
  • Macromolecular Substances
  • Nerve Tissue Proteins
  • Peptides
  • Tubulin
  • Vimentin
  • atrophin-1
  • Green Fluorescent Proteins
  • polyglutamine
  • Nocodazole